The topics of the presentation Oct 20th 11:00
Post# of 72440
11:00
-Update on Brilacidin development for bacterial skin infections
-Building a patient population for your clinical trials
Developing a stable manufacturing process for clinical and commercial scale expansion
-Transition between in-house and contract labs for clinical work
Dr Krishna Menon, Chief Scientific Officer, Cellceutix CORP
- See more at: http://www.terrapinn.com/conference/antimicro...Lo5Pn.dpuf
Know what you own